This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Harris, N. Articles by Millar, R. Search for Related Content PubMed PubMed Citation Articles by Harris, N. Articles by Millar, R.

Gonadotropin-releasing Hormone Gene Expression in MDA-MB-231 and ZR-75-1 Breast Carcinoma Cell Lines¹

Medical Research Council Regulatory Peptides Research Unit, Department of Chemical Pathology, University of Cape Town Medical School, Observatory 7925, South Africa [N. H., C. D., K. E., R. M.], and Fishberg Research Center in Neurobiology, Mount Sinai School of Medicine, New York, New York 10029 [K-W. D., J. R.]

The presence of gonadotropin-releasing hormone (GnRH)-binding sites in human breast carcinomas and breast tumor cell lines as well as the demonstration of the inhibitory effects of GnRH analogues on the growth of these cells raised the possibility that GnRH is produced locally by breast tumor cells themselves. Immunoreactive GnRH was shown to be present in acetic acid extracts of cultured MDA-MB-231 and ZR-75-1 breast carcinoma cells. These extracts were separated by high-performance liquid chromatography and were analyzed by means of region-specific antisera with differing GnRH sequence specificities. A peak of GnRH which coeluted with synthetic mammalian GnRH in 2 different high-performance liquid chromatography systems was similarly detected by antisera directed at the NH₂ terminus, at the middle portion and at the N and COOH termini together. The GnRH gene is expressed in these breast tumor lines, as determined by S1 nuclease protection assay, oligonucleotide primer extension studies, and polymerase chain reaction amplification of complementary DNA using oligonucleotides. The primer extension studies indicate that several forms of mRNA are present. The predominant form corresponds to the excision of intron I and the use of a start site about 60 bases upstream of intron I as in the human hypothalamus. Les usage is made of other start sites further upstream. Much larger species of mRNA were also present and correspond to the retention of intron I as in human placenta. The demonstration of GnRH gene expression and the presence of immunoreactive GnRH in mammary carcinoma cells known to have GnRH-binding sites and to be affected by GnRH analogues suggests that GnRH may serve an autocrine regulatory role.

¹ These studies were supported by the Medical Research Council and the National Cancer Association of South Africa and the University of Cape Town.

Received 10/18/88. Accepted 3/ 5/91.

This article has been cited by other articles:

				R. Lopez de Maturana, A. J. Pawson, Z.-L. Lu, L. Davidson, S. Maudsley, K. Morgan, S. P. Langdon, and R. P. Millar Gonadotropin-Releasing Hormone Analog Structural Determinants of Selectivity for Inhibition of Cell Growth: Support for the Concept of Ligand-Induced Selective Signaling Mol. Endocrinol., July 1, 2008; 22(7): 1711 - 1722. [Abstract] [Full Text] [PDF]

				C. K. Cheng and P. C. K. Leung Molecular Biology of Gonadotropin-Releasing Hormone (GnRH)-I, GnRH-II, and Their Receptors in Humans Endocr. Rev., April 1, 2005; 26(2): 283 - 306. [Abstract] [Full Text] [PDF]

				N Angelopoulos, V Barbounis, S Livadas, D Kaltsas, and G Tolis Effects of estrogen deprivation due to breast cancer treatment Endocr. Relat. Cancer, September 1, 2004; 11(3): 523 - 535. [Abstract] [Full Text] [PDF]

				G. Cobellis, R. Meccariello, S. Minucci, C. Palmiero, R. Pierantoni, and S. Fasano Cytoplasmic Versus Nuclear Localization of Fos-Related Proteins in the Frog, Rana esculenta, Testis: In Vivo and Direct In Vitro Effect of a Gonadotropin-Releasing Hormone Agonist Biol Reprod, March 1, 2003; 68(3): 954 - 960. [Abstract] [Full Text] [PDF]

				C.-S. Chou, H. Zhu, E. Shalev, C. D. MacCalman, and P. C. K. Leung The Effects of Gonadotropin-Releasing Hormone (GnRH) I and GnRH II on the Urokinase-Type Plasminogen Activator/Plasminogen Activator Inhibitor System in Human Extravillous Cytotrophoblasts in Vitro J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5594 - 5603. [Abstract] [Full Text] [PDF]

				R. M. Moretti, M. Montagnani Marelli, J. C. Van Groeninghen, and P. Limonta Locally Expressed LHRH Receptors Mediate the Oncostatic and Antimetastatic Activity of LHRH Agonists on Melanoma Cells J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3791 - 3797. [Abstract] [Full Text] [PDF]

				A. Chen, E. Kaganovsky, S. Rahimipour, N. Ben-Aroya, E. Okon, and Y. Koch Two Forms of Gonadotropin-releasing Hormone (GnRH) Are Expressed in Human Breast Tissue and Overexpressed in Breast Cancer: A Putative Mechanism for the Antiproliferative Effect of GnRH by Down-Regulation of Acidic Ribosomal Phosphoproteins P1 and P2 Cancer Res., February 1, 2002; 62(4): 1036 - 1044. [Abstract] [Full Text] [PDF]

				S. K. Kang, K.-C. Choi, C.-J. Tai, N. Auersperg, and P. C. K. Leung Estradiol Regulates Gonadotropin-Releasing Hormone (GnRH) and its Receptor Gene Expression and Antagonizes the Growth Inhibitory Effects of GnRH in Human Ovarian Surface Epithelial and Ovarian Cancer Cells Endocrinology, February 1, 2001; 142(2): 580 - 588. [Abstract] [Full Text] [PDF]

				S. K. Kang, C.-J. Tai, P. S. Nathwani, and P. C. K. Leung Differential Regulation of Two Forms of Gonadotropin-Releasing Hormone Messenger Ribonucleic Acid in Human Granulosa-Luteal Cells Endocrinology, January 1, 2001; 142(1): 182 - 192. [Abstract] [Full Text] [PDF]

				S. K. Kang, K.-C. Choi, K. W. Cheng, P. S. Nathwani, N. Auersperg, and P. C. K. Leung Role of Gonadotropin-Releasing Hormone as an Autocrine Growth Factor in Human Ovarian Surface Epithelium Endocrinology, January 1, 2000; 141(1): 72 - 80. [Abstract] [Full Text] [PDF]

				I. Palyi, B. Vincze, S. Lovas, I. Mezo, J. Pato, A. Kalnay, G. Turi, D. Gaal, R. Mihalik, I. Peter, et al. Gonadotropin-releasing hormone analogue conjugates with strong selective antitumor activity PNAS, March 2, 1999; 96(5): 2361 - 2366. [Abstract] [Full Text] [PDF]

				M. Kovacs, A. V. Schally, A. Nagy, M. Koppan, and K. Groot Recovery of pituitary function after treatment with a targeted cytotoxic analog of luteinizing hormone-releasing hormone PNAS, February 18, 1997; 94(4): 1420 - 1425. [Abstract] [Full Text] [PDF]